Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is -49.56% vs -35.54% in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is -15.46% vs -41.21% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is 3.01% vs 6.66% in Mar 2025
Compare Balance Sheet Results of Evonile Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
12.34
16.10
-3.76
-23.35%
Share Warrants & Outstandings
Total Reserve
805.49
1,181.64
-376.15
-31.83%
Shareholder's Funds
817.83
1,197.73
-379.90
-31.72%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-13.47
31.24
-44.71
-143.12%
Other Long Term Liabilities
1.72
5.19
-3.47
-66.86%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
13.75
1.90
11.85
623.68%
Total Non-Current Liabilities
2.00
38.33
-36.33
-94.78%
Current Liabilities
Trade Payables
54.65
110.85
-56.20
-50.70%
Other Current Liabilities
40.23
8.53
31.70
371.63%
Short Term Borrowings
0.00
0.00
0.00
0.00%
Short Term Provisions
50.09
1.67
48.42
2,899.40%
Total Current Liabilities
144.97
121.04
23.93
19.77%
Total Liabilities
964.80
1,357.11
-392.31
-28.91%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
5.80
790.87
-785.07
-99.27%
Less: Accumulated Depreciation
4.98
106.24
-101.26
-95.31%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.82
684.63
-683.81
-99.88%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
35.55
-35.55
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
98.52
-98.52
-100.00%
Long Term Loans & Advances
187.89
0.00
187.89
0.00%
Other Non Current Assets
5.78
1.58
4.20
265.82%
Total Non-Current Assets
196.55
824.80
-628.25
-76.17%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
53.32
159.60
-106.28
-66.59%
Sundry Debtors
37.05
219.45
-182.40
-83.12%
Cash and Bank
667.70
78.87
588.83
746.58%
Other Current Assets
3.05
9.25
-6.20
-67.03%
Short Term Loans and Advances
7.13
65.14
-58.01
-89.05%
Total Current Assets
768.25
532.30
235.95
44.33%
Net Current Assets (Including Current Investments)
623.28
411.26
212.02
51.55%
Total Current Assets Excluding Current Investments
768.25
532.30
235.95
44.33%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
964.80
1,357.11
-392.31
-28.91%
Contingent Liabilities
387.55
8.81
378.74
4,298.98%
Total Debt
0.00
0.00
0.00
0.00%
Book Value per share (adjusted)
278.93
148.81
130.12
87.44%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 0.00% vs -100.00% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 1.72 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -49.56% vs -35.54% in Mar 2025
Annual - Fixed Assets
Fixed Assets 0.82 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -15.46% vs -41.21% in Mar 2025
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 768.25 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 3.01% vs 6.66% in Mar 2025